N-[(N-CHLORAMBUCILAMINO)-UNDECANOYL]-PARA-HYDROXYPHENYL-L-PARA-TYROSINAMIDE
Compound with spectra: 1 NMR
![N-[(N-CHLORAMBUCILAMINO)-UNDECANOYL]-PARA-HYDROXYPHENYL-L-PARA-TYROSINAMIDE](/api/compound/1fgdi6GctWe.png?ph=true&h=300&w=458 "N-[(N-CHLORAMBUCILAMINO)-UNDECANOYL]-PARA-HYDROXYPHENYL-L-PARA-TYROSINAMIDE")
| SpectraBase Compound ID | 1fgdi6GctWe |
|---|---|
| InChI | InChI=1S/C40H54Cl2N4O5/c41-25-28-46(29-26-42)34-19-13-31(14-20-34)10-9-12-38(49)43-27-8-6-4-2-1-3-5-7-11-39(50)45-37(30-32-15-21-35(47)22-16-32)40(51)44-33-17-23-36(48)24-18-33/h13-24,37,47-48H,1-12,25-30H2,(H,43,49)(H,44,51)(H,45,50)/t37-/m0/s1 |
| InChIKey | ZFGGFDYDCYBSNU-QNGWXLTQSA-N |
| Mol Weight | 741.8 g/mol |
| Molecular Formula | C40H54Cl2N4O5 |
| Exact Mass | 740.347126 g/mol |
| Enantiomer InChIKey | ZFGGFDYDCYBSNU-DIPNUNPCSA-N |
| Racemate InChIKey | ZFGGFDYDCYBSNU-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | ACETONE-D6 |
N-[(N-CHLORAMBUCILAMINO)-HEXANOYL]-PARA-HYDROXYPHENYL-L-PARA-TYROSINAMIDE
N-[1-benzyl-2-(2-fluoroanilino)-2-oxoethyl]cyclohexanecarboxamide
(phenylmethyl) N-[1-[[4-(cyclohexylcarbamoyl)phenyl]amino]-1-oxidanylidene-3-phenyl-propan-2-yl]carbamate
2-Oxa-10,13-diazatricyclo[15.2.2.13,7]docosa-3,5,7(22),17,19,20-hexaene-11,14-dione, 12-[(4-hydroxyphenyl)methyl]-, (S)-
2-Oxa-11,14-diazatricyclo[15.2.2.13,7]docosa-3,5,7(22),17,19,20-hexaene-10,13-dione, 12-[(4-hydroxyphenyl)methyl]-, (S)-
TYROPEPTIN-B;N-BUTYRYL-L-TYROSYL-L-LEUCYL-DL-TYROSINAL
CATHESTATIN-C;(2S,3S,5S)-EPOXYSUCCINYL-TYROSYLCADAVERINE
TMC-52B
CATHESTATIN-B;(2S,3S,5S)-EPOXYSUCCINYL-TYROSYLPUTRESCINE
TMC-52A
| Title | Journal or Book | Year |
|---|---|---|
| Design of novel tyrosine-nitrogen mustard hybrid molecules active against uterine, ovarian and breast cancer cell lines | Steroids | 2012 |